Company Filing History:
5 out of 822 
3 out of 167 
1 out of 1 Years Active: 2014-2018
Title: Innovations and Achievements of Inventor Jorge Gandarilla
Introduction
Jorge Gandarilla is a prominent inventor based in North Riverside, Illinois, known for his contributions to the field of pharmaceuticals. With a total of five patents to his name, his work primarily focuses on developing innovative treatments for various medical conditions. His latest patents demonstrate his commitment to advancing medical science through unique chemical compounds and formulations.
Latest Patents
Gandarilla's latest innovations include significant contributions such as "Modulators of 5-HT receptors and methods of use thereof." This patent involves the creation of aryl- and heteroaryl-fused decahydropyrroloazepine compounds, along with methods for treating various disease conditions using these compounds. Additionally, he has been involved in the invention of "Macrocyclic hepatitis C serine protease inhibitors," which pertains to novel macrocyclic compounds that offer new therapeutic strategies for treating hepatitis C infections.
Career Highlights
Throughout his career, Jorge Gandarilla has worked with notable companies, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His work at these organizations has been integral to the development of innovative treatments in the pharmaceutical industry, showcasing his expertise and impact on healthcare solutions.
Collaborations
Gandarilla has had the opportunity to collaborate with esteemed colleagues, including Albert Wayne Kruger and Dennie S. Welch. Together, they have contributed to advancing pharmaceutical research and product development, further solidifying their impact in the field.
Conclusion
In summary, Jorge Gandarilla is a distinguished inventor whose work has led to the development of key pharmaceutical innovations. His latest patents exemplify his dedication to finding effective treatments for complex conditions. Through his collaborations and career highlights, Gandarilla continues to contribute significantly to the realm of medical science and innovation.